The Report “Ambrisentan – Comprehensive patent search” is now available at lifescienceindustryresearch.com. Contact sales@lifescienceindustryresearch.com Phone with “Ambrisentan – Comprehensive patent search″ in subject line and your contact details to purchase this report or get your questions answered. The collection of ‘Pharmaceuticals’ market research reports has a new addition of “Ambrisentan – Comprehensive patent search” on Lifescienceindustryresearch.com. Used by the world’s leading pharmaceutical companies and legal teams for over 10 years, Ark In-depth Searches are the benchmark in comprehensive, accurate and relevant patent data. Searched and analysed by highly trained, qualified staff using proprietary searching techniques, you won’t need to worry about missing patents or updating data. And that means your IP staff will be freed up to concentrate on your business, rather than getting bogged down in patent data. Purchase a copy of this report @ http://www.lifescienceindustryresearch.com/purchase?rname=431. Eliminate bottlenecks and free up months of expert manpower
Over 350 fully researched and updated patent searches by highly trained, qualified staff using proprietary searching techniques, available for instant online access Intuitive, easy to understand design provides vital documents at your fingertips Collaborate and share company knowledge with online access to notes and flags
Quickly grasp complexity
Identifies patents covering molecule, formulation, process, use, combinations and more Grouped by patent family and assigned to development categories based on interpretation of key aspects of the patent claims Manual filtration of patents so you only see what is relevant to you Covers the world’s major territories with equivalents in over 80 countries
Never miss a change in the patent landscape
Monthly updates to patent families, statuses, and litigation clearly identified Comprehensive litigation alerts linked to patent numbers Add your own notes, save searches and results
Single User License : US $7500; Inquire for Discount @ http://www.lifescienceindustryresearch.com/discount?rname=431. This report covers:
International Nonproprietary Name: Ambrisentan indications: Treatment of pulmonary arterial hypertension innovator:Gilead (Letairis); Glaxosmithkline (Volibris)
Country coverage:
The In-depth search contains patents from territories that are individually verified and monitored for changes, including British, German, Spanish, French, US, Canadian, Australian, European, and PCT patents. For other business research / market intelligence report on the ‘Pharmaceuticals’ market, contact sales@lifescienceindustryresearch.com / Call +1 888 391 5441.